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Assessment and Optimization of Kinetic Methods for Angiotensin-Converting Enzyme in Plasma

Joseph E. Buttery and Sandra Stuart
In the kineticangiotensin-converting enzyme (ACE) method, a practicaland optimal buffer is 80 mmolJLborate bufferat pH 8.2 (37 #{176}C). A lag phase is detected in the reaction, and a 5-mm incubation of substrate and plasma is suggested before the kinetic measurement. The substrate, N-[3-(2-furacryloyl]-L-phenyiaIanylgIycylgIycine (FAPGG), concentration is maximized at 1.0 mmoVL and the measurement wavelength is at 345 nm to ensure linearity of measurement. The proposed procedure uses a 1 .9 plasmato-reagent volume ratio. The linear range of the assay extends to -170 U/L, representinga 25% substrate hydrolysis.The FAPGG absorptMty is determined by measuring the difference in absorbance between 1.0 mmoVL FAPGG and the product solutions. The wavelength fidelity is checked by noting the expected absorbance value of the FAPGG solution, and a 1.0-nm deviation from 345 nm alters the absorbance by 15.5%. The precision of ACE assays at -60 and 100 U/L is 3.5% and 2.4% within batch and 2.9% and 2.6% between batch, respectiveiy. The referenceinterval (2.5th to 97.5th percentiles) is 41-139 U/L, and there is no difference between values for men and women.
Measurement of plasma angiotensin-converting en- and glycylglycine.
A disturbing feature of the kinetic method is the diversity of reference intervals quoted by different laboratories (3) . Several factors are thought to contribute to this diversity, including the incorrect use of millimolar absorbance change (A) in FAPGG (3) , small population sampling, lag phase and wavelength fidelity (4), and substrate concentration (5). We have also noted that different buffers and nonlinear absorbance of the assay affect ACE activity. We therefore examined the above issues more closely, which has led us to propose an improved kinetic ACE method that we present here. 
Proposed Procedure
Assessment Procedures and Results
Studies with the kinetic ACE method (2) were carried out with a 1:9 plasma-to-reagent volume ratio to investigate the various reaction variables.
Buffers
Tris (6, 7) , borate (2, 8), and HEPES (9, 10) buffers, all at pH 8.2 (37 #{176}C), were investigated to determine which was best for the ACE method. The assay was performed with FAPOG at 1.0 mmol/L and absorbance was measured at 345 nm ( Table 1 ). The ACE activity in borate buffer was higher than that in Tris buffer, contrary to the observations of Ronca-Testom (2), who showed them to be equal. Beneteau et al. (10) , experimenting with different buffers, showed that 25 mmolJL LIEPES gave the highest ACE activity, whereas we found that 50 mmol/L HEPES gave significantly higher ACE activity than did 25 mmol/L HEPES (P <0.001). ACE activity in 50 mmol/L HEPES was not significantly different from that in 80 mmol/L borate buffer. Because the HEPES buffer was near the pH limit of its buffering capacity, preference was given to the borate buffer. A double-strength borate buffer (2) should not be prepared, because diluting to 80 mmol/L with water will alter its pH by + 0.2. Our earlier report that different buffers did not influence the ACE activity was incorrect and was due to poor instrumentation
(3).
Lag Phase
The lag phase in the kinetic ACE method has not been adequately investigated and, consequently, preincubation times have ranged from 30s to 8 mm. Roulston and Allan (7) proposed an 8-mn preincubation for their modified ACE procedure, but they made no mention of a lag phase until a later publication (4).
We studied the lag phase in relation to our proposed method and to the method of Roulston and Allan, using sample-to-reagent volume ratios of 1:9 and 3:7, respectively. The substrate and plasma samples were warmed to 37#{176}C, mixed, and transferred into prewarmed cuvettes at 37#{176}C. The absorbance at 345 rim was noted every 20s for 15 mm. The Beckman spectrophotometer is able to calculate enzyme activities over any time period of the 15-mm reaction, and thus a lag phase (lower ACE activity) can be detected. A lag phase was detected in all but 1 of the 18 samples tested. The one sample with no measurable lag phase had a very high ACE activity (>450 UIL). The average lag phase was 4 mm (range 2-8 mm) for the 1:9 volume ratio, whereas with the 3:7 volume ratio the average was 5 mm (range 2-10 min). Hence, the lag phase alluded to by Roulston 
(4) is very real.
A problem associated with the high sample-to-reagent volume ratio is the increased absorbance due to the sample. A slightly turbid sample can have an absorbance of 0.3-0.4A at 345 mm for the 1:9 volume ratio, and this increases substantially when the ratio is 3:7, making measurement of the ACE reaction nonlinear. In the above lag-phase study, the samples used were all visually clear and the reaction absorbances were within the linear range.
We noted that, in every instance, ACE activity measured in different plasma samples with the 3:7 ratio was lower than that measured with the 1:9 ratio. On average, the activities of 15 samples were 20% lower, 2 were 36% lower, and 1 was 68% lower. The activities (mean ± SD) were 57 ± 27 and 70 ± 31 U/L for the 3:7 and 1:9 ratios, respectively. Thus the high sample-to-reagent 
Maximizing FAPGG Concentration
An optimal substrate concentration is not possible because of the high and nonlinear absorbance of FAPGG. The nonlinearity problem is overcome by using lower substrate concentrations (6) or short light-path cuvettes (7). Thus a 0.75 mmol/L FAPGG solution measured at 334 mm with a 5-mm cuvette (6) and a 1.0 mmol/L FAPGG solution measured at 334 rim with a 4-mm cuvette (7) were proposed for the Multistat ifi analyzer and the Cobas Fara, respectively. These measurement variables may not apply to other instruments because of nonlinear absorbance.
In a study involving the comparison of using 0.75 and 1.0 mmol/L FAPGG to determine ACE activity, ACE activities from 17 samples were 104 ± 42 and 114 ± 46 U/L, respectively. The measurements were performed at 345 mm with 10-mm cuvettes to ensure linearity. The former results were significantly lower (P <0.001), confirming that measured ACE activity increases with increasing FAPGG concentration. This difference in substrate concentration leading to higher ACE activity was also postulated by Maguire and Price (5).
A further comparison of ACE activity was made with 1.0 mmol/L FAPGG and measuring at 340 and 345 mm. ACE activities from 12 samples were 83 ± 38 and 101 ± 39 U/L respectively (P <0.001). This finding is a consequence of the nonlinear absorbance of FAPGG at 340 nm (Figure 1) . The factors used to determine ACE activity were determined from the enzymatic hydrolysis of 1.0 mmol/L FAPGG measured at the two wavelengths.
Enzyme Activity
The time (7, 9) is an insensitive method for assessinglinear hydrolysis, becausethe small absorbance changes are difficult to monitor. It therefore is not strictly correct to state that substrate hydrolysis can proceed linearly to 25-40%. In practice, a 25% substrate hydrolysis is tolerated, and by our method this translates to -170 U/L.
Assay Sensitivity
Greater sensitivity with the ACE method, as judged by a larger absorbance change when FAPGG is hydrolyzed, was claimed when measurement was at 334 mm instead of 340 mm (6). The relationship between sensitivity and linearity was investigated by observing the absorbance change between the FAPGG substrate and a solution with 20% substrate hydrolysis. The latter is a mixture of 80% FAPGG and 20% FAP such that the total concentration is either 0.75 or 1.0 mmol/L. Measurements were taken at 334, 340, and 345 mm for the different solutions ( Table 2) .
The absorbance change resulting from the difference between the substrate absorbance and the absorbance after 20% hydrolysis is a measure of the ACE activity from the theoretical hydrolysis of 20% of the substrate. Measured at 334 mmthis absorbance change (A3) from 0.75 mmol/L FAPGG is the same as that measured at 345 nm (A6) from 1.0 mmolIL FAPGG. When absorbance is converted into ACE activity, the result is higher at 345 mm than at 334 rim. There is therefore no sensitivity advantage in choosing 334 mm as the measurement wavelength because, although higher absorbance readings are obtained, the final absorbance change is not greater than that at 345 mu. This is again due to the nonlinear absorbance at 334 mm. In any case, use of the lower concentration of FAPGG will give lower ACE activity, as was also observed from the study of 0.75 vs 1.0 mmol/L FAPGG described earlier.
Wavelength Fidelity
A solution of FAPGG shows strong absorbance at 345 nm, and any slight variation in wavelength fidelity substantially alters the absorbance and the apparent change in absorbance during the reaction (14) . Wavelength fidelity can be investigated by measuring the absorbance of 1.0 mmol/L FAPGG solution and a 20% hydrolyzed substrate solution at 343-347 mu and noting the absorbance change for the two solutions ( Table 3 ).
The change varies greatly with different wavelengths. A variation of 1.0 mm from 345 nm gives -12% error from the correct ACE activity. In practice, the quality-control sample can serve as a monitor of wavelength fidelity in the absence of other factors. A large unexplained variation in the quality-control result could be due to an inaccurate wavelength setting. This can be quickly confirmed from the absorbance of the substrate solution.
A simpler approach to check for wavelength fidelity is to note the absorbanceof 1.0 mmolIL FAPGG before the assay. A 1.0-mm deviation from 345 mm alters the substrate absorbance by 15.5%, and this change should alert the analyst to a possible error in wavelength setting. Hence, appropriate wavelength adjustment can be made to obtain the correct value.
Discussion
The assay is linear to 170 UIL. For samples with higher activity, a smaller sample volume is used. Instrurnents such as the DU-70 spectrophotometer, which is able to determine ACE activity over any interval during the assay, can measure higher activity before 25% substrate exhaustion.
Hence, activity as great as 300 U/L can be recalculated from the initial 4-5 min reaction time.
The within-run precisions determined for two plasma samples with ACE activities of 59 and 164 U/L (n = 6 each) are 3.5% and 2.4%, respectively. The between-run precisions for two plasma samples with ACE activities of 68 and 163 UIL (n = 10 each) are 2.9% and 2.6%.
The inclusion of a control serum is an integral part of our quality-control program in the ACE assay. The Ciba Corning normal unassayed serum (Ciba Corning DiagnosticsCorp., Irvine, CA) is a convenient quality-control sample used to monitor the assay.
A reference interval was established with our proposed method by using Statgraphics, version 5 (STSC Inc., Rockville, MD) on data from 133 healthy blood donors (64 men, 69 women). A plot of the distribution showed it to be fairly symmetrical with a slight righttail skew for the men, women, and total population. There was no significant difference between men and women. The reference interval determined from the 2.5th to 97.5th percentiles is 41-139 U/L.
In conclusion, we recommend using the borate buffer in the kinetic ACE procedure. A lag phase of 5 mm is We thank David Gee for his interest and helpful suggestions.
